Dutogliptin, a selective DPP4 inhibitor, improves glycaemic control in patients with type 2 diabetes: a 12‐week, double‐blind, randomized, placebo‐controlled, multicentre trial
- DOI
- 10.1111/j.1463-1326.2010.01195.x
- Published
- 2010-02-25
- Container
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/j.1463-1326.2010.01195.x,
title = {Dutogliptin, a selective DPP4 inhibitor, improves glycaemic control in patients with type 2 diabetes: a 12‐week, double‐blind, randomized, placebo‐controlled, multicentre trial},
author = {H. M. R. Pattzi and S. Pitale and M. Alpizar and C. Bennett and A. M. O’Farrell and J. Li and J. M. Cherrington and H.‐P. Guler and Unknown},
year = {2010},
journal = {Diabetes, Obesity and Metabolism},
doi = {10.1111/j.1463-1326.2010.01195.x},
url = {https://doi.org/10.1111/j.1463-1326.2010.01195.x}
}RIS
TY - JOUR TI - Dutogliptin, a selective DPP4 inhibitor, improves glycaemic control in patients with type 2 diabetes: a 12‐week, double‐blind, randomized, placebo‐controlled, multicentre trial AU - H. M. R. Pattzi AU - S. Pitale AU - M. Alpizar AU - C. Bennett AU - A. M. O’Farrell AU - J. Li AU - J. M. Cherrington AU - H.‐P. Guler AU - Unknown PY - 2010 JO - Diabetes, Obesity and Metabolism DO - 10.1111/j.1463-1326.2010.01195.x UR - https://doi.org/10.1111/j.1463-1326.2010.01195.x ER -
APA
Pattzi, H. M. R., Pitale, S., Alpizar, M., Bennett, C., O’Farrell, A. M., Li, J., Cherrington, J. M., Guler, H., & Unknown (2010). Dutogliptin, a selective DPP4 inhibitor, improves glycaemic control in patients with type 2 diabetes: a 12‐week, double‐blind, randomized, placebo‐controlled, multicentre trial. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/j.1463-1326.2010.01195.x
Source records
- crossref · retrieved 2026-09-25T21:31:08.123Z